Clover Health to Report Second Quarter 2025 Financial Results on August 5, 2025
Rhea-AI Summary
Clover Health (NASDAQ:CLOV) has scheduled its Second Quarter 2025 earnings release and conference call for August 5, 2025. The financial results will be released after market close, followed by a conference call and webcast at 5:00 p.m. Eastern Time.
Investors can access the conference call by dialing 800-245-3047 (U.S.) or 203-518-9765 (international) with conference ID CLOVQ225. A live and archived webcast will be available on the company's investor relations website for 12 months.
Positive
- None.
Negative
- None.
News Market Reaction – CLOV
In the trading session that priced this news, CLOV gained 5.54%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WILMINGTON, Del., July 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Tuesday, August 5, 2025. Company management will host a conference call and webcast at 5:00 p.m. Eastern Time on the same day to discuss the company’s business and financial performance for the quarter.
Second Quarter 2025 Conference Call and Webcast Details:
- What: Clover Health’s Second Quarter 2025 Earnings Conference Call
- When: Tuesday, August 5, 2025, at 5:00 p.m. Eastern Time
- Dial In: To access the call via telephone please dial 800-245-3047 (for U.S. callers) or 203-518-9765 (for callers outside the U.S.) and enter the conference ID: CLOVQ225
- Webcast: A live and archived webcast of the conference call will be accessible from the Investor Relations section of Clover Health’s website at https://investors.cloverhealth.com/ for 12 months
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence and Congestive Heart Failure, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Investor Relations:
Ryan Schmidt
investors@cloverhealth.com
Press Inquiries:
press@cloverhealth.com
